Physician

Miriam Yvette Atkins, M.D.

According to 2025 Medicare claims, Miriam Atkins, M.D. (NPI: 1649257890) practices hematology/oncology in the Augusta-Richmond County, GA-SC market, with the plurality of this provider's patient population coming from Aiken, SC. This provider's primary affiliated billing organization is AUGUSTA ONCOLOGY ASSOCIATES PC (NPI: 1912917824; TIN: 581481590) and primary practice location at 30909-6520.

Atkins' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,239 traditional Medicare patients, billed 185,899 HCPCS/CPT codes, and received $2,368,484 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,410 prescription claims across 443 beneficiaries totaling $3,302,532 in drug costs, led by Cabometyx (Cabozantinib S-Malate). DME data shows 18 claims. Open Payments data shows 190 records totaling $3,929. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,592,214 to $3,302,532. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $6,852 to $492.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	782	139,456	$1,994,665
2016	758	171,895	$2,565,311
2017	833	202,022	$2,426,855
2018	1,063	220,445	$2,680,430
2019	1,039	225,508	$2,709,858
2020	1,039	229,803	$2,762,004
2021	1,081	246,143	$2,728,274
2022	1,114	225,257	$2,578,064
2023	1,184	186,013	$2,111,712
2024	1,239	185,899	$2,368,484

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	355	2,620	$1,592,214
2016	373	2,679	$1,898,074
2017	408	2,765	$2,133,588
2018	471	2,914	$2,734,955
2019	535	3,309	$3,079,459
2020	455	3,146	$2,670,589
2021	485	3,188	$4,422,058
2022	459	2,650	$4,754,844
2023	424	2,464	$3,827,938
2024	443	2,410	$3,302,532

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	13	158	$29,909
2016	13	65	$3,355
2017	13	28	$2,017
2018	15	104	$11,848
2019	15	111	$8,205
2020	N/R	42	$2,747
2021	N/R	103	$6,382
2022	N/R	34	$3,093
2023	N/R	23	$939
2024	N/R	18	$1,532

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	382	532	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	292	361	$63
80053	Blood test, comprehensive group of blood chemicals	827	1,348	$10
36415	Insertion of needle into vein for collection of blood sample	925	1,696	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	902	1,648	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Cabometyx	Cabozantinib S-Malate	17	510	$446,709
Lenalidomide	Lenalidomide	21	588	$366,081
Kisqali	Ribociclib Succinate	31	868	$354,477
Xtandi	Enzalutamide	25	750	$345,100
Ibrance	Palbociclib	19	532	$293,115

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	N/R	18	$1,532

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	190	$3,929	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Miriam Yvette Atkins, M.D.?

Tedicare shows public-source Medicare data for Miriam Yvette Atkins, M.D. (NPI 1649257890), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Miriam Yvette Atkins, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Miriam Yvette Atkins, M.D.?

Miriam Yvette Atkins, M.D. is linked to AUGUSTA ONCOLOGY ASSOCIATES PC (billing NPI 1912917824) in the available physician profile data.

Does Miriam Yvette Atkins, M.D. have Open Payments data?

Miriam Yvette Atkins, M.D. has 190 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.